Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 01, 2018
- Source ID
- 10.1016/j.neuroimage.2018.08.040
Entities
People
- Jiu-chiuan Chen
- Joann E. Manson
- Kathleen M. Hayden
- Mark A. Espeland
- Ramon Casanova
- Robert B. Wallace
- Ryan T. Barnard
- Santiago Saldana
- Sarah A. Gaussoin
- Stephen R. Rapp
- Susan M. Resnick
Organizations
- AbbVie
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Chiron Corporation
- Eisai
- Eli Lilly and Company
- GE HealthCare
- Hoffmann-La Roche
- Innogenetics
- Johnson & Johnson
- Laboratoires Servier
- Lundbeck
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Heart, Lung, and Blood Institute
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Perrigo Company Plc
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense